相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA
Lingling Kong et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen
Claudia D. Wurster et al.
JOURNAL OF NEUROLOGY (2020)
Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients
Irene Faravelli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Neurofilament as a potential biomarker for spinal muscular atrophy
Basil T. Darras et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy
Didu S. T. Kariyawasam et al.
FRONTIERS IN NEUROLOGY (2019)
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with Nusinersen
Andreas Totzeck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders
Yichen Lee et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response
Haiyan Zhou et al.
HUMAN MOLECULAR GENETICS (2015)
Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
Ching-Hua Lu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation
Shingo Kariya et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
Haiyan Zhou et al.
HUMAN GENE THERAPY (2013)
Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1G93A Mice that Model ALS
Ching-Hua Lu et al.
PLOS ONE (2012)
A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament hook effect
Ching-Hua Lu et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Biogenesis of spliceosomal small nuclear ribonucleoproteins
Utz Fischer et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration
Rodolphe Perrot et al.
MOLECULAR NEUROBIOLOGY (2008)
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study
E Mercuri et al.
NEUROMUSCULAR DISORDERS (2006)
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
W Rossoll et al.
JOURNAL OF CELL BIOLOGY (2003)
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding
ML McWhorter et al.
JOURNAL OF CELL BIOLOGY (2003)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)